ZYME CIK: 1937653

Zymeworks Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
288
FY22:
545
FY23:
413
FY24:
300
FY25:
249
(positive)
Change from FY21 to FY25
millions USD
FY21:
101
FY22:
104
FY23:
168
FY24:
163
FY25:
97.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
389
FY22:
649
FY23:
581
FY24:
463
FY25:
347

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
71.9
FY22:
95.6
FY23:
55.8
FY24:
88.3
FY25:
42.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
68.2
FY22:
60.1
FY23:
60.3
FY24:
36.0
FY25:
35.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
249
FY22:
493
FY23:
465
FY24:
339
FY25:
269
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
389
FY22:
649
FY23:
581
FY24:
463
FY25:
347

All amounts in millions USD Data source:SEC EDGAR